1 study on Mapk erk signaling mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
**TNBC patients currently have no approved targeted therapy**, making every mechanistically distinct druggable axis clinically meaningful. The finding that `SV1` — not the canonical `GHRH-R` — dominates receptor expre…